Spots Global Cancer Trial Database for pancreatic ductal carcinoma(pda)
Every month we try and update this database with for pancreatic ductal carcinoma(pda) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | NCT01839487 | Metastatic Panc... | PEGPH20 Nab-paclitaxel Gemcitabine Dexamethasone Enoxaparin | 18 Years - | Halozyme Therapeutics | |
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | NCT01839487 | Metastatic Panc... | PEGPH20 Nab-paclitaxel Gemcitabine Dexamethasone Enoxaparin | 18 Years - | Halozyme Therapeutics |